ClinicalTrials.Veeva

Menu

Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires (PH-HIBA)

H

Hospital Italiano de Buenos Aires

Status

Enrolling

Conditions

Hypertension, Pulmonary Arterial

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.

Full description

The Institutional Registry of Pulmonary Hypertension includes patients prospectively with incident pulmonary hypertension type I. It also includes prevalent cases from our HMO who had diagnosis prior the beginning of the registry.

Enrollment

200 estimated patients

Sex

All

Ages

17+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • Inclusion Criteria:

    1. Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) >15 mmHg and pulmonary vascular resistance (PVR) >2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
    2. Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
    3. Aged ≥18 years at the index date.
  • Exclusion Criteria History of lung transplantation surgery previously the baseline period

Trial contacts and locations

1

Loading...

Central trial contact

Ignacio M Bluro, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems